First patient enrolled in Oxford BioDynamics' ALS biomarker study
First patient enrolled in Oxford BioDynamics’ ALS biomarker study
First patient enrolled in Oxford BioDynamics’ ALS biomarker study - PharmaTimes Oxford BioDynamics welcomes commencement of new US clinical trial Oxford BioDynamics welcomes commencement of new US clinical trial, 25 Oct 2�19 �7:22 | Shares Magazine Haven't heard of new trial start in a while; today we have two. |
All times are GMT -5. The time now is 06:49 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.